跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SINCALIDE FOR INJECTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
SINCALIDE FOR INJECTION
Authorized
STANDARD
SINCALIDE FOR INJECTION
avir pharma inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
b4cb963deb91f480
Company
avir pharma inc.
Type
Standard
Approval Details
Approval Id
b4cb963deb91f480
Drug Approval Canada Name
SINCALIDE FOR INJECTION
Product Name
SINCALIDE FOR INJECTION
Status
Marketed
Status Date
2023-08-03
Original Market Date
2023-08-03
Din
02494361
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intravenous
Schedule
Ethical
Ahfs
36:34.00
Atc Original
V04CC03 SINCALIDE
Atc Name
v 04 cc 03
Aig Number
0113162001
Company Name
avir pharma inc.
Company Address
660 Boulevard Industriel, Blainville, Quebec, Canada, J7C 3V4
Active Ingredients
SINCALIDE
5 MCG / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
b4cb963deb91f480
Type
Standard
Back to Health Canada Approvals